Back to search
FDAFDA · Food and drugs·Recall number D-0984-2016

ESTRADIOL VALERATE 40MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121

Published June 15, 2016 · Recall initiated: May 17, 2016

Summary

FDA records drug Class II recall D-0984-2016, published June 15, 2016 and initiated May 17, 2016. Recalling firm: Well Care Compounding Pharmacy; Status: Terminated; Reported quantity: 869 Units (Total All Products); Lot: Lot #: 02162016:85@45, Exp. 5/17/2016; Lot #:03092016:30@19, Exp. 06/07/2016; Lot #: 01282016:77@25, Exp.05/03/2016; Lot #: 3112016:98@21, Exp. 06/13/2016; Lot #:03242016:52@22, Exp. 06/27/2016; Lot #: 04122016:15@50, Exp. 7/11/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Well Care Compounding Pharmacy
Distributor
NV
Lot
Lot #: 02162016:85@45, Exp. 5/17/2016; Lot #:03092016:30@19, Exp. 06/07/2016; Lot #: 01282016:77@25, Exp.05/03/2016; Lot #: 3112016:98@21, Exp. 06/13/2016; Lot #:03242016:52@22, Exp. 06/27/2016; Lot #: 04122016:15@50, Exp. 7/11/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was ESTRADIOL VALERATE 40MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121 recalled?

Yes. FDA published recall D-0984-2016 on June 15, 2016. Reported hazard: Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release